CAPLAN ARNOLD I has a total of 22 patent applications. Its first patent ever was published in 1984. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are YANAGA HIROKO, MAO JEREMY J and ATALA ANTHONY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | Australia | 3 | |
#5 | Italy | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Object sterilising | |
#3 | Microorganisms | |
#4 | Implantable devices | |
#5 | Peptides | |
#6 | Unspecified technologies | |
#7 | Therapeutic chemical compounds | |
#8 | Analysing materials | |
#9 | Milling |
# | Name | Total Patents |
---|---|---|
#1 | Caplan Arnold I | 22 |
#2 | Haynesworth Stephen E | 7 |
#3 | Syftestad Glenn T | 6 |
#4 | Dennis James E | 2 |
#5 | Syftestad Glen T | 2 |
#6 | Cohen Nir | 1 |
Publication | Filing date | Title |
---|---|---|
US2014314869A1 | Isolating and therapeutic use of perivascular medicinal cells | |
WO2004084950A2 | Cell targeting methods and compositions | |
AU669850B2 | Monoclonal antibodies specific for marrow-derived mesenchymal cells | |
US5197985A | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells | |
US5226914A | Method for treating connective tissue disorders | |
WO8504173A1 | Bone protein purification process | |
AU4153985A | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites | |
US4620327A | Process of adapting soluble bone protein for use in stimulating osteoinduction |